CryoPort, Inc. (NASDAQ:CYRX) hit a new 52-week high during trading on Wednesday . The stock traded as high as $8.54 and last traded at $8.53, with a volume of 266,052 shares trading hands. The stock had previously closed at $8.08.

CYRX has been the topic of several research analyst reports. Janney Montgomery Scott set a $8.00 target price on CryoPort and gave the company a “buy” rating in a research report on Wednesday, July 26th. Needham & Company LLC upped their target price on CryoPort from $6.00 to $8.50 and gave the company a “buy” rating in a research report on Wednesday, July 26th. ValuEngine upgraded CryoPort from a “sell” rating to a “hold” rating in a research report on Thursday, May 11th. Finally, Cowen and Company upped their target price on CryoPort from $5.50 to $7.50 and gave the company an “outperform” rating in a research report on Wednesday, August 9th.

The company’s 50 day moving average is $6.90 and its 200 day moving average is $4.35. The firm’s market cap is $210.72 million.

CryoPort (NASDAQ:CYRX) last posted its quarterly earnings data on Tuesday, August 8th. The company reported ($0.08) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.09) by $0.01. The business had revenue of $2.92 million for the quarter, compared to analysts’ expectations of $2.84 million. CryoPort had a negative return on equity of 67.75% and a negative net margin of 102.89%. Equities research analysts forecast that CryoPort, Inc. will post ($0.72) earnings per share for the current year.

Institutional investors have recently bought and sold shares of the business. Taylor Wealth Management Partners bought a new stake in CryoPort during the 2nd quarter valued at approximately $1,851,000. BerganKDV Wealth Management LLC boosted its position in CryoPort by 157.5% during the 2nd quarter. BerganKDV Wealth Management LLC now owns 25,750 shares of the company’s stock valued at $127,000 after acquiring an additional 15,750 shares in the last quarter. EAM Investors LLC bought a new stake in CryoPort during the 2nd quarter valued at approximately $552,000. Vanguard Group Inc. boosted its position in CryoPort by 96.9% during the 2nd quarter. Vanguard Group Inc. now owns 519,100 shares of the company’s stock valued at $2,554,000 after acquiring an additional 255,519 shares in the last quarter. Finally, Northern Trust Corp boosted its position in CryoPort by 105.0% during the 2nd quarter. Northern Trust Corp now owns 22,179 shares of the company’s stock valued at $109,000 after acquiring an additional 11,358 shares in the last quarter. 12.05% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: This article was posted by Daily Political and is owned by of Daily Political. If you are reading this article on another site, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/09/06/cryoport-inc-cyrx-hits-new-12-month-high-at-8-54.html.

About CryoPort

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.